Introduction to asthma and phenotyping

Regina A. Pillai, William Calhoun

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Asthma is an inflammatory disorder characterized by airway obstruction, airway hyperresponsiveness, and airway inflammation, all of which are variable among patients and variable in time within any specific patient. Understanding the mechanism that underlies this observed variability, and using that understanding to advance the science of asthma and the care of asthmatic patients, is an essential purpose of developing phenotypes. Clinical phenotypes have been used for decades, but overlap each other, and do not map cleanly to either pathophysiologic mechanism or with therapeutic response. Molecular phenotyping, although as yet only partially developed, offers the promise of dissecting the mechanistic underpinnings of the variability of asthma and of providing predictive therapeutics for the benefit of patients with this common and troubling disease.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages5-15
Number of pages11
Volume795
ISBN (Print)9781461486022
DOIs
StatePublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
Volume795
ISSN (Print)00652598

Fingerprint

Asthma
Phenotype
Airway Obstruction
Patient Care
Inflammation
Therapeutics

Keywords

  • Asthma
  • Clinical phenotypes
  • Clusters
  • Heterogeneity
  • Induced phenotype
  • Molecular phenotype
  • Physiology
  • Treatment

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Pillai, R. A., & Calhoun, W. (2014). Introduction to asthma and phenotyping. In Advances in Experimental Medicine and Biology (Vol. 795, pp. 5-15). (Advances in Experimental Medicine and Biology; Vol. 795). Springer New York LLC. https://doi.org/10.1007/978-1-4614-8603-9_1

Introduction to asthma and phenotyping. / Pillai, Regina A.; Calhoun, William.

Advances in Experimental Medicine and Biology. Vol. 795 Springer New York LLC, 2014. p. 5-15 (Advances in Experimental Medicine and Biology; Vol. 795).

Research output: Chapter in Book/Report/Conference proceedingChapter

Pillai, RA & Calhoun, W 2014, Introduction to asthma and phenotyping. in Advances in Experimental Medicine and Biology. vol. 795, Advances in Experimental Medicine and Biology, vol. 795, Springer New York LLC, pp. 5-15. https://doi.org/10.1007/978-1-4614-8603-9_1
Pillai RA, Calhoun W. Introduction to asthma and phenotyping. In Advances in Experimental Medicine and Biology. Vol. 795. Springer New York LLC. 2014. p. 5-15. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-8603-9_1
Pillai, Regina A. ; Calhoun, William. / Introduction to asthma and phenotyping. Advances in Experimental Medicine and Biology. Vol. 795 Springer New York LLC, 2014. pp. 5-15 (Advances in Experimental Medicine and Biology).
@inbook{ae485585b8594cafb932582fcfa195c2,
title = "Introduction to asthma and phenotyping",
abstract = "Asthma is an inflammatory disorder characterized by airway obstruction, airway hyperresponsiveness, and airway inflammation, all of which are variable among patients and variable in time within any specific patient. Understanding the mechanism that underlies this observed variability, and using that understanding to advance the science of asthma and the care of asthmatic patients, is an essential purpose of developing phenotypes. Clinical phenotypes have been used for decades, but overlap each other, and do not map cleanly to either pathophysiologic mechanism or with therapeutic response. Molecular phenotyping, although as yet only partially developed, offers the promise of dissecting the mechanistic underpinnings of the variability of asthma and of providing predictive therapeutics for the benefit of patients with this common and troubling disease.",
keywords = "Asthma, Clinical phenotypes, Clusters, Heterogeneity, Induced phenotype, Molecular phenotype, Physiology, Treatment",
author = "Pillai, {Regina A.} and William Calhoun",
year = "2014",
doi = "10.1007/978-1-4614-8603-9_1",
language = "English (US)",
isbn = "9781461486022",
volume = "795",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "5--15",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Introduction to asthma and phenotyping

AU - Pillai, Regina A.

AU - Calhoun, William

PY - 2014

Y1 - 2014

N2 - Asthma is an inflammatory disorder characterized by airway obstruction, airway hyperresponsiveness, and airway inflammation, all of which are variable among patients and variable in time within any specific patient. Understanding the mechanism that underlies this observed variability, and using that understanding to advance the science of asthma and the care of asthmatic patients, is an essential purpose of developing phenotypes. Clinical phenotypes have been used for decades, but overlap each other, and do not map cleanly to either pathophysiologic mechanism or with therapeutic response. Molecular phenotyping, although as yet only partially developed, offers the promise of dissecting the mechanistic underpinnings of the variability of asthma and of providing predictive therapeutics for the benefit of patients with this common and troubling disease.

AB - Asthma is an inflammatory disorder characterized by airway obstruction, airway hyperresponsiveness, and airway inflammation, all of which are variable among patients and variable in time within any specific patient. Understanding the mechanism that underlies this observed variability, and using that understanding to advance the science of asthma and the care of asthmatic patients, is an essential purpose of developing phenotypes. Clinical phenotypes have been used for decades, but overlap each other, and do not map cleanly to either pathophysiologic mechanism or with therapeutic response. Molecular phenotyping, although as yet only partially developed, offers the promise of dissecting the mechanistic underpinnings of the variability of asthma and of providing predictive therapeutics for the benefit of patients with this common and troubling disease.

KW - Asthma

KW - Clinical phenotypes

KW - Clusters

KW - Heterogeneity

KW - Induced phenotype

KW - Molecular phenotype

KW - Physiology

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84934443156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934443156&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8603-9_1

DO - 10.1007/978-1-4614-8603-9_1

M3 - Chapter

SN - 9781461486022

VL - 795

T3 - Advances in Experimental Medicine and Biology

SP - 5

EP - 15

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -